RSH Respiri Secures Major Investment to Power US Expansion and...

RSH Respiri Secures Major Investment to Power US Expansion and Propel Cash Flow Positive Trajectory.

RSH Respiri has received a significant $27.5 million investment boost, solidifying its US expansion and propelling it towards a cash flow positive future.

This investment underscores the strong investor confidence in RSH Respiri's innovative Wheezo AI remote patient monitoring technology and its potential to revolutionize healthcare.

Key Highlights:$7.5 Million Oversubscribed Private Placement: RSH Respiri successfully secured $7.5 million through an oversubscribed private placement, demonstrating the immense investor interest in their mission.

Experienced Investor Backing: A renowned RPM investor provided $5 million of the funding, signifying the belief in RSH Respiri's ability to disrupt the healthcare landscape.

Cash Flow Positive by 2024: RSH Respiri anticipates reaching cash flow break-even by late 2024, fueled by the strategic allocation of funds for key acquisitions and expansion initiatives.$20 Million Equity Investment Facility: An additional $20 million equity investment facility has been secured for future acquisitions, empowering RSH Respiri to further scale its remote patient monitoring business.

Leading the US Healthcare System: This investment reinforces RSH Respiri's commitment to becoming a leading player in the US healthcare system, improving patient care and delivering cost-effective solutions.Validation of Wheezo AI Strategy:

Managing Director Marjan Mikel emphasizes that this investment validates the Wheezo AI strategy and propels RSH Respiri towards achieving crucial milestones without seeking additional funding.

Looking Ahead:With this substantial financial backing, RSH Respiri is well-positioned to capitalize on its momentum and achieve its ambitious goals. The acquisition of Access Managed Services LLC and the expansion of its Centers of Medicare and Medicaid reimbursed RPM business in the US will be key drivers of its growth. Furthermore, the potential for future acquisitions through the $20 million equity investment facility promises further expansion and market leadership.RSH Respiri's commitment to innovation and its focus on improving patient outcomes make it a force to be reckoned with in the healthcare industry. With this substantial investment, the company is poised to achieve significant milestones and solidify its position as a leading provider of cutting-edge remote patient monitoring solutions.

RSH could have a ripper of a year - Its cashed up and taunting breakeven this year.